110 related articles for article (PubMed ID: 26458650)
1. Clear cell hepatocellular carcinoma: Back to the basics for diagnosis.
Sakhuja P; Mishra PK; Rajesh R; Sharma AK; Gondal R; Singh M
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458650
[TBL] [Abstract][Full Text] [Related]
2. Clear cell carcinoma of the liver: a case report.
Kilinç N; Yalçin K; Değertekin H; Ozaydin M
Turk J Gastroenterol; 2003 Sep; 14(3):211-4. PubMed ID: 14655070
[TBL] [Abstract][Full Text] [Related]
3. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature.
Zhang W; Wang Q; Jiang YX; Lu Q; Yu WJ; Liu Y; Liu YL; Zhao H; Zhuang J; Li YJ
Int J Clin Exp Pathol; 2015; 8(1):995-9. PubMed ID: 25755808
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
6. Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.
Shah S; Gupta S; Shet T; Maheshwari A; Wuntkal R; Mohandas KM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):306-7. PubMed ID: 15908336
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral sampling variability in hepatocellular carcinoma: a case report.
Senes G; Fanni D; Cois A; Uccheddu A; Faa G
World J Gastroenterol; 2007 Aug; 13(29):4019-21. PubMed ID: 17663522
[TBL] [Abstract][Full Text] [Related]
8. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
9. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
Geramizadeh B; Boub R; Rahsaz M
Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
[TBL] [Abstract][Full Text] [Related]
10. [Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
Yip YC; Wang FH; Vong HT; Zhang M; Wen JM
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):626-9. PubMed ID: 22177248
[TBL] [Abstract][Full Text] [Related]
11. Aspiration cytodiagnosis of clear cell hepatocellular carcinoma in an elderly woman. A case report.
Gupta RK; AlAnsari AG; Fauck R
Acta Cytol; 1994; 38(3):467-9. PubMed ID: 7514835
[TBL] [Abstract][Full Text] [Related]
12. [Clear cell hepatocellular carcinoma].
Mansinho H; Ferreira M; Fernandes A; Chaves P; Assis e Santos
Acta Med Port; 1993; 6(8-9):397-400. PubMed ID: 8279278
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3 and Hep Par-1 are Useful Biomarkers in the Cytologic Assessment of Ascites.
Cabibi D; Bisanti A; Lanza D; Brucculeri V; Porcasi R; Ingrao S; Midiri F; Picone D; Giannone AG
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):65-69. PubMed ID: 30383541
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma.
Nguyen T; Phillips D; Jain D; Torbenson M; Wu TT; Yeh MM; Kakar S
Arch Pathol Lab Med; 2015 Aug; 139(8):1028-34. PubMed ID: 26230595
[TBL] [Abstract][Full Text] [Related]
15. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
Fan Z; van de Rijn M; Montgomery K; Rouse RV
Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
[TBL] [Abstract][Full Text] [Related]
16. Clear cell hepatocellular carcinoma treated with liver transplantation.
Pecorella I; Ciardi A; Aiello E; Piras MR; Farci C; Di Tondo U
Pathologica; 1994 Jun; 86(3):307-10. PubMed ID: 7808805
[TBL] [Abstract][Full Text] [Related]
17. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.
Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A
J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063
[TBL] [Abstract][Full Text] [Related]
18. New Names for Old Tumors.
Wong M; Waters KM; Guindi M; Larson BK
Am J Clin Pathol; 2021 Apr; 155(5):698-710. PubMed ID: 33258899
[TBL] [Abstract][Full Text] [Related]
19. Clear cell hepatocellular carcinoma diagnosed by bile duct brushing cytology.
Fu LY; Mitchell KA; Cai G
Diagn Cytopathol; 2016 Feb; 44(2):147-51. PubMed ID: 26638110
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous metastasis of hepatocellular carcinoma diagnosed by fine needle aspiration cytology and Hep Par 1 immunopositivity.
Isa NM; Bong JJ; Ghani FA; Rose IM; Husain S; Azrif M
Diagn Cytopathol; 2012 Nov; 40(11):1010-4. PubMed ID: 21563319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
